Operating Income Summary of Aspen Pharmacare Holdings Limited

Aspen Pharmacare Holdings Limited's latest annual operating income in 2023 was 6.99 Billion ZAR , down -10.53% from previous year.
Aspen Pharmacare Holdings Limited's latest quarterly operating income in 2023 Q2 was 3.5 Billion ZAR , up 100.0% from previous quarter.
Aspen Pharmacare Holdings Limited reported an annual operating income of 7.82 Billion ZAR in 2022, down -9.79% from previous year.
Aspen Pharmacare Holdings Limited reported an annual operating income of 8.67 Billion ZAR in 2021, up 22.61% from previous year.
Aspen Pharmacare Holdings Limited reported a quarterly operating income of 3.49 Billion ZAR for 2023 Q4, down 0.0% from previous quarter.
Aspen Pharmacare Holdings Limited reported a quarterly operating income of 1.75 Billion ZAR for 2023 Q1, down -66.1% from previous quarter.

Annual Operating Income Chart of Aspen Pharmacare Holdings Limited (2023 - 2002)

Historical Annual Operating Income of Aspen Pharmacare Holdings Limited (2023 - 2002)

Year	Operating Income	Operating Income Growth
2023	6.99 Billion ZAR	-10.53%
2022	7.82 Billion ZAR	-9.79%
2021	8.67 Billion ZAR	22.61%
2020	7.07 Billion ZAR	0.17%
2019	7.06 Billion ZAR	46.81%
2018	4.8 Billion ZAR	-47.94%
2017	9.23 Billion ZAR	11.29%
2016	8.3 Billion ZAR	-7.78%
2015	9 Billion ZAR	6.51%
2014	8.44 Billion ZAR	13.81%
2013	7.42 Billion ZAR	47.22%
2012	5.04 Billion ZAR	27.98%
2011	3.94 Billion ZAR	25.14%
2010	3.14 Billion ZAR	20.43%
2009	2.61 Billion ZAR	19.78%
2008	2.18 Billion ZAR	77.12%
2007	1.23 Billion ZAR	14.48%
2006	1.07 Billion ZAR	11.18%
2005	968.35 Million ZAR	27.61%
2004	758.82 Million ZAR	37.03%
2003	553.76 Million ZAR	23.92%
2002	446.85 Million ZAR	0.0%

Year	Operating Income	Operating Income Growth
2023 Q2	3.5 Billion ZAR	100.0%
2023 Q4	3.49 Billion ZAR	0.0%
2023 Q1	1.75 Billion ZAR	-66.1%
2022 Q4	5.16 Billion ZAR	105.17%
2022 Q1	1.94 Billion ZAR	-55.56%
2022 Q2	4.34 Billion ZAR	123.05%
2022 Q3	2.51 Billion ZAR	-42.08%
2022 FY	7.82 Billion ZAR	-9.79%
2021 Q1	2.27 Billion ZAR	-42.62%
2021 FY	8.67 Billion ZAR	22.61%
2021 Q2	4.83 Billion ZAR	112.29%
2021 Q3	2.09 Billion ZAR	-56.78%
2021 Q4	4.38 Billion ZAR	109.61%
2020 FY	7.07 Billion ZAR	0.17%
2020 Q3	1.77 Billion ZAR	-62.18%
2020 Q2	4.69 Billion ZAR	166.82%
2020 Q1	1.76 Billion ZAR	-65.95%
2020 Q4	3.97 Billion ZAR	123.65%
2019 Q3	1.7 Billion ZAR	-63.25%
2019 FY	7.06 Billion ZAR	46.81%
2019 Q4	5.16 Billion ZAR	202.63%
2019 Q1	1.53 Billion ZAR	-64.94%
2019 Q2	4.64 Billion ZAR	202.21%
2018 Q2	2.06 Billion ZAR	0.0%
2018 FY	4.8 Billion ZAR	-47.94%
2018 Q4	4.38 Billion ZAR	62.6%
2018 Q3	2.69 Billion ZAR	30.53%
2018 Q1	2.06 Billion ZAR	-12.06%
2017 Q3	2.35 Billion ZAR	0.0%
2017 Q1	2.35 Billion ZAR	-8.65%
2017 FY	9.23 Billion ZAR	11.29%
2017 Q4	2.35 Billion ZAR	0.0%
2017 Q2	2.35 Billion ZAR	0.0%
2016 Q2	2.3 Billion ZAR	0.0%
2016 FY	8.3 Billion ZAR	-7.78%
2016 Q4	2.57 Billion ZAR	0.0%
2016 Q3	2.57 Billion ZAR	11.87%
2016 Q1	2.3 Billion ZAR	12.2%
2015 Q3	2.05 Billion ZAR	-32.79%
2015 Q4	2.05 Billion ZAR	0.0%
2015 FY	9 Billion ZAR	6.51%
2015 Q1	3.05 Billion ZAR	42.47%
2015 Q2	3.05 Billion ZAR	0.0%
2014 Q1	2.15 Billion ZAR	-7.13%
2014 FY	8.44 Billion ZAR	13.81%
2014 Q4	2.14 Billion ZAR	0.0%
2014 Q3	2.14 Billion ZAR	-0.85%
2014 Q2	2.15 Billion ZAR	0.0%
2013 FY	7.42 Billion ZAR	47.22%
2013 Q4	2.32 Billion ZAR	0.0%
2013 Q3	2.32 Billion ZAR	61.45%
2013 Q2	1.44 Billion ZAR	0.0%
2013 Q1	1.44 Billion ZAR	9.63%
2012 Q1	1.24 Billion ZAR	26.14%
2012 Q3	1.31 Billion ZAR	5.71%
2012 FY	5.04 Billion ZAR	27.98%
2012 Q4	1.31 Billion ZAR	0.0%
2012 Q2	1.24 Billion ZAR	0.0%
2011 Q3	985.15 Million ZAR	25.14%
2011 Q1	787.25 Million ZAR	0.0%
2011 Q4	985.15 Million ZAR	0.0%
2011 Q2	787.25 Million ZAR	0.0%
2011 FY	3.94 Billion ZAR	25.14%
2010 Q4	787.25 Million ZAR	0.0%
2010 Q2	653.72 Million ZAR	0.0%
2010 FY	3.14 Billion ZAR	20.43%
2010 Q3	787.25 Million ZAR	20.43%
2010 Q1	653.72 Million ZAR	0.0%
2009 Q3	653.72 Million ZAR	19.78%
2009 FY	2.61 Billion ZAR	19.78%
2009 Q1	545.75 Million ZAR	0.0%
2009 Q4	653.72 Million ZAR	0.0%
2009 Q2	545.75 Million ZAR	0.0%
2008 FY	2.18 Billion ZAR	77.12%
2008 Q4	545.75 Million ZAR	0.0%
2008 Q3	545.75 Million ZAR	77.12%
2008 Q2	308.12 Million ZAR	0.0%
2008 Q1	308.12 Million ZAR	0.0%
2007 Q1	269.15 Million ZAR	0.0%
2007 Q2	269.15 Million ZAR	0.0%
2007 Q3	308.12 Million ZAR	14.48%
2007 FY	1.23 Billion ZAR	14.48%
2007 Q4	308.12 Million ZAR	0.0%
2006 Q3	269.15 Million ZAR	11.18%
2006 Q2	242.08 Million ZAR	0.0%
2006 Q1	242.08 Million ZAR	0.0%
2006 Q4	269.15 Million ZAR	0.0%
2006 FY	1.07 Billion ZAR	11.18%
2005 Q1	189.7 Million ZAR	0.0%
2005 FY	968.35 Million ZAR	27.61%
2005 Q3	242.08 Million ZAR	27.61%
2005 Q4	242.08 Million ZAR	0.0%
2005 Q2	189.7 Million ZAR	0.0%
2004 Q1	138.44 Million ZAR	0.0%
2004 FY	758.82 Million ZAR	37.03%
2004 Q3	189.7 Million ZAR	37.03%
2004 Q4	189.7 Million ZAR	0.0%
2004 Q2	138.44 Million ZAR	0.0%
2003 Q2	111.71 Million ZAR	0.0%
2003 Q4	138.44 Million ZAR	0.0%
2003 Q3	138.44 Million ZAR	23.92%
2003 FY	553.76 Million ZAR	23.92%
2003 Q1	111.71 Million ZAR	0.0%
2002 FY	446.85 Million ZAR	0.0%
2002 Q4	111.71 Million ZAR	0.0%
2002 Q3	111.71 Million ZAR	0.0%

Peer Operating Income Comparison of Aspen Pharmacare Holdings Limited

Name	Operating Income	Operating Income Difference

Global Stocks Search

Aspen Pharmacare Holdings Limited (APN.JO)

Operating Income Summary of Aspen Pharmacare Holdings Limited

Annual Operating Income Chart of Aspen Pharmacare Holdings Limited (2023 - 2002)

Historical Annual Operating Income of Aspen Pharmacare Holdings Limited (2023 - 2002)

Peer Operating Income Comparison of Aspen Pharmacare Holdings Limited